Article
Clonal expansion of cancer driver gene mutants investigated using advanced sequencing technologies.
Mutation research. Reviews in mutation research - 1 Jan 2024
Parsons Barbara L
Abstract excerpt
Advanced sequencing technologies (ASTs) have revolutionized the quantitation of cancer driver mutations (CDMs) as rare events, which has utility in clinical oncology, cancer research, and cancer risk assessment. This review focuses on studies that have used ASTs to characterize clonal expansion (CE) of cells carrying CDMs and to explicate the selective pressures that shape CE. Importantly, high-sensitivity ASTs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
